David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
CALL
Applied Materials
AMAT
$384B
| $26.9M | 0.03% |
679,500
+251,400
| +59% | +$9.55M |
|
577
Integra LifeSciences
IART
$1.3B
| $26.9M | 0.03% |
483,286
+47,297
| +11% | +$2.41M |
|
578
PUT
Equinix
EQIX
$104B
| $26.9M | 0.03% |
59,300
+39,300
| +197% | +$16M |
|
579
Green Dot
GDOT
$765M
| $26.8M | 0.03% |
442,460
+352,714
| +393% | +$24.6M |
|
|
XEC
580
DELISTED
CIMAREX ENERGY CO
XEC
| $26.7M | 0.03% |
382,244
+227,780
| +147% | +$16.4M |
|
|
IRBT
581
DELISTED
iRobot
IRBT
| $26.6M | 0.03% |
226,208
+198,086
| +704% | +$21.1M |
|
582
NCR Voyix
VYX
$1.1B
| $26.6M | 0.03% |
1,586,877
+345,710
| +28% | +$5.73M |
|
583
Emerson Electric
EMR
$87.9B
| $26.5M | 0.03% |
387,662
-160,727
| -29% | -$10.6M |
|
584
TSMC
TSM
$2.13T
| $26.5M | 0.03% |
647,970
-180,272
| -22% | -$6.88M |
|
585
CALL
Target
TGT
$77.2B
| $26.5M | 0.03% |
329,800
+138,300
| +72% | +$10.1M |
|
586
PUT
Verizon
VZ
$208B
| $26.4M | 0.03% |
446,600
-1,401,400
| -76% | -$79.4M |
|
|
OPTU
587
Optimum Communications Inc
OPTU
$328M
| $26.4M | 0.03% |
1,227,610
-95,043
| -7% | -$1.92M |
|
|
VIAB
588
DELISTED
Viacom Inc. Class B
VIAB
| $26.3M | 0.03% |
938,362
+55,262
| +6% | +$1.59M |
|
589
Comcast
CMCSA
$95.9B
| $26.2M | 0.03% |
655,323
-1,307,699
| -67% | -$49.2M |
|
590
Progress Software
PRGS
$1.78B
| $26.2M | 0.03% |
589,587
+316,203
| +116% | +$11.6M |
|
591
Knowles
KN
$2.78B
| $26.1M | 0.03% |
1,482,117
+345,650
| +30% | +$5.35M |
|
592
Chemours
CC
$2.32B
| $26.1M | 0.03% |
702,399
-333,940
| -32% | -$12.2M |
|
|
AVB
593
DELISTED
AvalonBay Communities
AVB
| $26.1M | 0.03% |
129,968
-38,081
| -23% | -$7.28M |
|
594
Boston Properties
BXP
$11.2B
| $26.1M | 0.03% |
194,651
+76,537
| +65% | +$9.83M |
|
595
PUT
ExxonMobil
XOM
$675B
| $26.1M | 0.03% |
322,500
-649,400
| -67% | -$49.5M |
|
596
CALL
NXP Semiconductors
NXPI
$56.1B
| $26M | 0.03% |
294,500
-1,058,200
| -78% | -$93M |
|
597
Signet Jewelers
SIG
$3.24B
| $26M | 0.03% |
958,422
+679,960
| +244% | +$18.8M |
|
598
Waters Corp
WAT
$40.4B
| $25.9M | 0.03% |
103,055
+25,721
| +33% | +$5.86M |
|
599
CALL
DuPont de Nemours
DD
$18.5B
| $25.9M | 0.03% |
191,991
+89,480
| +87% | +$12.4M |
|
|
BLUE
600
CALL
DELISTED
bluebird bio
BLUE
| $25.9M | 0.03% |
12,715
-2,447
| -16% | -$4.31M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.